Results 271 to 280 of about 193,970 (395)

Molecular profile and clinical impact of MDM2 amplification in patients with advanced biliary tract cancer. [PDF]

ESMO Open
Yoon H, Jeong H, Park I, Chang HM, Kim D, Sung CO, Lee JS, Ryoo BY, Kim KP, Yoo C.   +9 more
europepmc   +1 more source

Orthotopic liver transplantation in the mouse [PDF]

, 1991
Demetris, AJ, Fung, JJ, Ildstad, ST, Qian, S, Starzl, TE   +4 more
core   +2 more sources

The real-world clinical effectiveness of durvalumab in advanced biliary tract cancer: a mimic comparative analysis through survival data reconstruction. [PDF]

Front Immunol
Ji HX, Si MH, Sun Z, Yang N, Chen Z.
europepmc   +1 more source

Which liver-disease patients need a transplant? [PDF]

, 1988
Gordon, RD, Iwatsuki, S, Kahn, D, Klintmalm, G, Koneru, B, Makowka, L, Marsh, JW, Sher, L, Starzl, TE, Staschak, S, Stieber, A, Todo, S, Tzakis, AG, Van Thiel, D   +13 more
core  

323P Early safety and efficacy from the phase IIIb TOURMALINE study of durvalumab (D) in combination with gemcitabine (G)-based chemotherapy in advanced biliary tract cancer (aBTC) [PDF]

D-Y. Oh, Masafumi Ikeda, T. Macarulla Mercadé, A.R. He, J.O. Park, M. Kitano, Ángela Lamarca, David Tai, F. Dayyani, Tiziana Pressiani, G. Barrie Wetherill, A. Stell, Peng Sun, Brittany Baur, Arndt Vogel   +14 more
openalex   +1 more source

Gastroenterological disorders and hepatic disease in adults with cerebral palsy: A systematic review

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To describe the incidence, prevalence, and prognostic factors for gastroenterological disorders and hepatic disease in adults with cerebral palsy (CP), and to examine the effectiveness of any screening or interventions. Method Six databases were searched for articles published in any language since 1990 meeting eligibility criteria ...
Christina M. Marciniak, Jennifer M. Ryan, Alejandra Camacho‐Soto, Emily Capellari, Jessica Burke, Maram Sofiany, Zoë Post, Eric C. Sung, Michael D. Brown, the Adult Cerebral Palsy Clinical Practice Guidelines Working Group, Jennifer M Ryan, Rachel Byrne, Emily Capellari, Donna Riccio Omichinski, Mark Peterson, Jan Willem Gorter, Ashley Harris Whaley, Christine Imms, Christina M. Marciniak   +18 more
wiley   +1 more source

Impact of Bone Metastases and Actionable Genetic Alterations in Biliary Tract Cancer. [PDF]

Cancers (Basel)
El-Shakankery KH, Kefas J, Andaleeb R, Muehlschlegel P, Bridgewater J.   +4 more
europepmc   +1 more source

Diabetes management in maternally inherited diabetes and deafness (MIDD): A review and a proposed treatment algorithm

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disorder usually caused by the variant m.3243A>G in the MT‐TL1 gene. We have proposed that diabetes in MIDD arises from a combination of insulin resistance and impaired β‐cell function that is more likely to occur in the presence of high skeletal muscle heteroplasmy and ...
Ahsen Chaudhry, David M. Thompson, Jean‐Pierre Chanoine   +2 more
wiley   +1 more source

Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer. [PDF]

Future Sci OA
Hu Y, Wei J, Sun X, Chen G, Su T, Yang Z, Lu X, Jin L.   +7 more
europepmc   +1 more source

Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) have been established as effective treatments for type 2 diabetes, offering benefits beyond glycaemic control; however, their associations across multiple health outcomes remain insufficiently assessed.
Dongjin Yeo, Yeona Jo, Jinyoung Jeong, Yi Deun Jeong, Ho Geol Woo, Yejun Son, Sunyoung Kim, Sang Youl Rhee, Dong Keon Yon   +8 more
wiley   +1 more source